<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="pha2" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">pha2</book-part-id>
      <title-group>
        <title>Pseudohypoaldosteronism Type II</title>
        <alt-title alt-title-type="alt-title">Synonyms: Gordon&#x02019;s Syndrome, Familial Hyperkalemic Hypertension, PHAII</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ellison</surname>
            <given-names>David H</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Oregon Health &#x00026; Science University<break/>Portland, Oregon</aff>
          <email>ellisond@ohsu.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>10</day>
          <month>11</month>
          <year>2011</year>
        </date>
        <date date-type="updated">
          <day>16</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="psach" document-type="chapter">Pseudoachondroplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="pxe" document-type="chapter">Pseudoxanthoma Elasticum</related-object>
      <abstract id="pha2.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Pseudohypoaldosteronism type II (PHAII) is characterized by hyperkalemia despite normal glomerular filtration rate (GFR) and frequently by hypertension. Other associated findings in both children and adults include hyperchloremia, metabolic acidosis, and suppressed plasma renin levels. Aldosterone levels are variable, but are relatively low given the degree of hyperkalemia (elevated serum potassium is a potent stimulus for aldosterone secretion). Hypercalciuria is well described.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of PHAII is established in a proband:</p>
          <list list-type="bullet">
            <list-item>
              <p>With hyperkalemia (in the setting of normal glomerular filtration), hypertension, metabolic acidosis, hyperchloremia, and suppressed plasma renin levels;</p>
              <p>AND/OR</p>
            </list-item>
            <list-item>
              <p>By the identification of a heterozygous pathogenic variant in <italic toggle="yes">CUL3</italic>, <italic toggle="yes">WNK1</italic>, or <italic toggle="yes">WNK4</italic> or a heterozygous pathogenic variant or biallelic pathogenic variants in <italic toggle="yes">KLHL3</italic>.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Electrolyte and blood pressure abnormalities of PHAII in children and adults are often corrected with thiazide diuretics.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Control of blood pressure is important to reduce the risk of cardiovascular and renal disease and stroke.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine electrolyte and blood pressure measurements.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Untreated individuals with PHAII should avoid excessive intake of foods high in salt and potassium as these may exacerbate hypertension and hyperkalemia.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Measurement of serum potassium concentration and blood pressure or identification of the known familial <italic toggle="yes">CUL3, KLHL3</italic>, <italic toggle="yes">WNK1</italic>, and <italic toggle="yes">WNK4</italic> pathogenic variant(s) in first-degree relatives of individuals with PHAII allows for early diagnosis and treatment .</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Affected pregnant women should undergo routine monitoring of electrolytes and blood pressure, with adjustments to antihypertensive medication dosage as needed. Some antihypertensive medications, including thiazide diuretics, have been associated with adverse fetal outcome, especially when taken during the first trimester of pregnancy; referral to an obstetrics group with expertise in high risk pregnancies should be considered.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>PHAII is frequently inherited in an autosomal dominant manner; PHAIID (caused by pathogenic variants in <italic toggle="yes">KLHL3</italic>) may also be inherited in an autosomal recessive manner. Many pathogenic variants in <italic toggle="yes">CUL3</italic> arise <italic toggle="yes">de novo</italic> and are not inherited from a parent. Each child of an individual with autosomal dominant PHAII has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant(s) in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="pha2.Diagnosis">
        <title>Diagnosis</title>
        <p>No formal diagnostic criteria for PHAII have been published.</p>
        <sec id="pha2.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Pseudohypoaldosteronism type II (PHAII) <bold>should be suspected</bold> in individuals with the following clinical features, supportive laboratory findings, and family history.</p>
          <p><bold>Clinical features.</bold> Hypertension (blood pressure &#x0003e;140/90 mm Hg) generally manifesting in adolescence or adulthood but also reported in children. Note: The absence of frank hypertension does not preclude the diagnosis.</p>
          <p>
            <bold>Supportive laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Hyperkalemia in the absence of impaired glomerular filtration</p>
              <list list-type="bullet">
                <list-item>
                  <p>Serum concentration of potassium ranges from mildly (serum K ~5.0-6.0 mmol/L) to severely elevated (&#x0003e;8.0 mmol/L) (normal range: ~3.5-5.1 mmol/L).</p>
                </list-item>
                <list-item>
                  <p>This finding is nearly universal in affected individuals at all ages.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Metabolic acidosis: serum concentration of bicarbonate ranging from 14 to 24 mmol/L (normal range: ~22-29 mmol/L)</p>
            </list-item>
            <list-item>
              <p>Hyperchloremia: serum concentration of chloride ranging from 105 to 117 mmol/L (normal range: ~99-108 mmol/L)</p>
            </list-item>
            <list-item>
              <p>Suppressed plasma renin levels</p>
            </list-item>
            <list-item>
              <p>Variable serum aldosterone levels that tend to be relatively suppressed in the context of hyperkalemia</p>
            </list-item>
            <list-item>
              <p>Serum calcium and parathyroid hormone levels that are normal. However, hypercalciuria is noted in at least a subset of individuals.</p>
            </list-item>
          </list>
          <p><bold>Family history.</bold> A first-degree relative with similar findings. Note: Absence of a family history of a first-degree relative with similar findings does not preclude the diagnosis.</p>
        </sec>
        <sec id="pha2.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of PHAII <bold>is established</bold> in a proband with hyperkalemia (in the setting of normal glomerular filtration) often accompanied by hypertension, metabolic acidosis, hyperchloremia and suppressed plasma renin levels <bold>and/or</bold> by the identification of a heterozygous pathogenic variant in <italic toggle="yes">CUL3,</italic>
<italic toggle="yes">KLHL3</italic>, <italic toggle="yes">WNK1</italic>, or <italic toggle="yes">WNK4</italic> or biallelic pathogenic variants in <italic toggle="yes">KLHL3</italic> (see <xref ref-type="table" rid="pha2.T.molecular_genetic_testing_used_in">Table 1</xref>). Note: PHAII is sometimes referred to by a subtype designation based on the associated gene; see <xref ref-type="sec" rid="pha2.Nomenclature">Nomenclature</xref>.</p>
          <p>Molecular genetic testing approaches can include <bold>serial single-gene testing</bold> and use of a <bold>multi-gene panel</bold>.</p>
          <p>
            <bold>Serial single-gene testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>It is reasonable to perform sequence analysis for pathogenic variants in <italic toggle="yes">CUL3</italic> and/or <italic toggle="yes">KLHL3</italic> first.</p>
            </list-item>
            <list-item>
              <p>If only one pathogenic variant in <italic toggle="yes">KLHL3</italic> is identified in an individual in whom autosomal recessive inheritance is suspected, gene-targeted deletion/duplication analysis of <italic toggle="yes">KLHL3</italic> should be considered.</p>
            </list-item>
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">WNK4</italic> may be performed next.</p>
            </list-item>
            <list-item>
              <p>If no pathogenic variant is identified through sequencing of <italic toggle="yes">WNK4</italic>, gene-targeted deletion/duplication analysis of <italic toggle="yes">WNK1</italic> may be considered next.</p>
            </list-item>
            <list-item>
              <p>If no disease-causing deletion or duplication is found in <italic toggle="yes">WNK1</italic>, consider sequencing of <italic toggle="yes">WNK1</italic>.</p>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CUL3,</italic>
<italic toggle="yes">KLHL3</italic>, <italic toggle="yes">WNK1</italic>, and <italic toggle="yes">WNK4</italic> and other genes of interest (see <xref ref-type="sec" rid="pha2.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
          <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <table-wrap id="pha2.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Pseudohypoaldosteronism Type II</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_2">Proportion of PHAII Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CUL3</italic>
                  </td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">25/86 families reported</td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">All reported cases to date</td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KLHL3</italic>
                  </td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">41/86 families reported&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Autosomal dominant: 29/86<break/>Autosomal recessive: 12/86</td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">WNK1</italic>
                  </td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">8/86 families reported</td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">See footnote 7</td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">2/2&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">WNK4</italic>
                  </td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">8/86 families reported</td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">All reported cases to date</td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4/52&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_pha2.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="pha2.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="pha2" object-id="pha2.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="pha2.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="pha2.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="pha2.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="pha2.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="pha2.TF.1.5">
                <label>5. </label>
                <p>Both heterozygous (autosomal dominant) and biallelic (autosomal recessive) pathogenic variants in <italic toggle="yes">KLHL3</italic> cause PHAII [<xref ref-type="bibr" rid="pha2.REF.mayan.2004.4025">Mayan et al 2004</xref>, <xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>, <xref ref-type="bibr" rid="pha2.REF.picard.2015a.e79">Picard et al 2015a</xref>, <xref ref-type="bibr" rid="pha2.REF.mitani.2016.127">Mitani et al 2016</xref>].</p>
              </fn>
              <fn id="pha2.TF.1.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
              <fn id="pha2.TF.1.7">
                <label>7. </label>
                <p>Recently, six kindreds (9 individuals) were reported in preliminary results to have pathogenic missense variants in <italic toggle="yes">WNK1</italic> (detailed in <xref ref-type="sec" rid="pha2.Molecular_Genetics">Molecular Genetics</xref>).</p>
              </fn>
              <fn id="pha2.TF.1.8">
                <label>8. </label>
                <p>Two large deletions have been reported (see <xref ref-type="sec" rid="pha2.Molecular_Genetics">Molecular Genetics</xref>) [<xref ref-type="bibr" rid="pha2.REF.wilson.2001.1107">Wilson et al 2001</xref>].</p>
              </fn>
              <fn id="pha2.TF.1.9">
                <label>9. </label>
                <p>An additional locus on 1q31-q42 has been identified as harboring a gene associated with PHAII [<xref ref-type="bibr" rid="pha2.REF.mansfield.1997.202">Mansfield et al 1997</xref>]. The identity of this gene is unknown. PHAII has been reported in at least ten families that lack identifiable pathogenic variants in <italic toggle="yes">CUL3</italic>, <italic toggle="yes">KLHL3</italic>, <italic toggle="yes">WNK1</italic>, and <italic toggle="yes">WNK4</italic> [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>, <xref ref-type="bibr" rid="pha2.REF.glover.2014.721">Glover et al 2014</xref>].</p>
              </fn>
              <fn id="pha2.TF.1.10">
                <label>10. </label>
                <p>Denominator is from the only report to document the number of PHAII individuals who did not have variants in <italic toggle="yes">CUL3</italic>, <italic toggle="yes">KLHL3</italic>, <italic toggle="yes">WNK1</italic>, or <italic toggle="yes">WNK4</italic> [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="pha2.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="pha2.Clinical_Description">
          <title>Clinical Description</title>
          <p>Pseudohypoaldosteronism type II (PHAII) is characterized by hyperkalemia despite normal glomerular filtration rate (GFR) and frequently by hypertension. More than 180 individuals and families with PHAII have been reported.</p>
          <p>The clinical presentation of PHAII is heterogeneous. The most consistent clinical feature in both children and young adults is hyperkalemia [<xref ref-type="bibr" rid="pha2.REF.gordon.1986.93">Gordon 1986</xref>]. As with essential hypertension, blood pressure is usually normal in young persons, with hypertension developing later in life. Untreated individuals with elevated blood pressure are at risk of developing complications of hypertension including cardiac disease, renal impairment, and stroke.</p>
          <p>Other associated findings in both children and adults include hyperchloremia, metabolic acidosis, and suppressed plasma renin levels. Aldosterone levels are variable, but are relatively low given the degree of hyperkalemia (elevated serum potassium is a potent stimulus for aldosterone secretion). Hypercalciuria is also well described in PHAII [<xref ref-type="bibr" rid="pha2.REF.mayan.2004.4025">Mayan et al 2004</xref>].</p>
          <p>Other features reported in a subset of individuals with PHAII include short stature, myalgias, periodic paralysis, and dental abnormalities [<xref ref-type="bibr" rid="pha2.REF.gordon.1986.93">Gordon 1986</xref>]. It has been suggested that these findings may be more prevalent in individuals with severe hyperkalemia and metabolic acidosis; however, exceptions have been reported [<xref ref-type="bibr" rid="pha2.REF.gordon.1986.93">Gordon 1986</xref>, <xref ref-type="bibr" rid="pha2.REF.farfel.2011.1547">Farfel et al 2011</xref>].</p>
        </sec>
        <sec id="pha2.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p>Individuals with a heterozygous <italic toggle="yes">CUL3</italic> pathogenic variant tend to have more severe hyperkalemia and metabolic acidosis, earlier development of hypertension, and greater likelihood of growth impairment compared to those harboring <italic toggle="yes">KLHL3</italic>, <italic toggle="yes">WNK1</italic>, or <italic toggle="yes">WNK4</italic> alterations [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>].</p>
          <p>In general, clinical manifestations of PHAII appear to be milder in individuals with a heterozygous <italic toggle="yes">WNK1</italic> or <italic toggle="yes">WNK4</italic> pathogenic variant compared to those with a heterozygous <italic toggle="yes">CUL3</italic> or a heterozygous or biallelic <italic toggle="yes">KLHL3</italic> pathogenic variant(s) [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>].</p>
          <p>Individuals with biallelic <italic toggle="yes">KLHL3</italic> pathogenic variants may have a more severe phenotype than individuals with a heterozygous pathogenic variant in <italic toggle="yes">KLHL3</italic> [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>, <xref ref-type="bibr" rid="pha2.REF.louisditpicard.2012">Louis-Dit-Picard et al 2012</xref>].</p>
        </sec>
        <sec id="pha2.Nomenclature">
          <title>Nomenclature</title>
          <p>The term &#x0201c;pseudohypoaldosteronism&#x0201d; has historically been used to describe the finding of persistent hyperkalemia despite the presence of normal or elevated serum levels of aldosterone [<xref ref-type="bibr" rid="pha2.REF.schambelan.1981.716">Schambelan et al 1981</xref>]. The term was initially used to describe persons with an inherited disorder characterized by hyperkalemia, elevated serum aldosterone, and volume depletion (now referred to as pseudohypoaldosteronism type I).</p>
          <p>Therefore, the term &#x0201c;pseudohypoaldosteronism&#x0201d; is a misnomer in the context of PHAII, as affected individuals have hyperkalemia with hypertension (instead of volume depletion). Some authorities prefer the descriptive name familial hyperkalemic hypertension (FHHt) for this reason.</p>
          <p>PHAII is sometimes referred to by a subtype designation based on the associated gene, as follows:</p>
          <list list-type="bullet">
            <list-item>
              <p>PHA type IIA (PHA2A): Unknown genetic cause (see <xref ref-type="table" rid="pha2.T.molecular_genetic_testing_used_in">Table 1</xref>, footnotes 9 and 10)</p>
            </list-item>
            <list-item>
              <p>PHA type IIB (PHA2B): <italic toggle="yes">WNK4</italic></p>
            </list-item>
            <list-item>
              <p>PHA type IIC (PHA2C): <italic toggle="yes">WNK1</italic></p>
            </list-item>
            <list-item>
              <p>PHA type IIE (PHA2E): <italic toggle="yes">CUL3</italic></p>
            </list-item>
            <list-item>
              <p>PHA type IID (PHA2D): <italic toggle="yes">KLHL3</italic></p>
            </list-item>
          </list>
        </sec>
        <sec id="pha2.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of the disorder is unknown. To date more than 180 individuals and families with PHAII have been reported.</p>
        </sec>
      </sec>
      <sec id="pha2.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">WNK1.</italic></bold>
<related-object link-type="booklink" source-id="gene" document-id="hsan2" document-type="chapter">Hereditary sensory and autonomic neuropathy type IIA</related-object> (HSAN2A) is associated with apparent loss-of function variants in specific exons of <italic toggle="yes">WNK1</italic>. Missense variants in <italic toggle="yes">WNK1</italic> have been reported in association with hypokalemic salt-losing tubulopathy in two unrelated individuals [<xref ref-type="bibr" rid="pha2.REF.zhang.2013.545">Zhang et al 2013</xref>].</p>
        <p><bold><italic toggle="yes">CUL3, KLHL3,</italic></bold>
<bold><italic toggle="yes">WNK4.</italic></bold> No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">CUL3</italic>, <italic toggle="yes">KLHL3</italic>, or <italic toggle="yes">WNK4.</italic></p>
      </sec>
      <sec id="pha2.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Hyperkalemia resulting from the following can generally be distinguished from hyperkalemia caused by PHAII on the basis of plasma renin levels, which are increased in the following conditions and suppressed in PHAII.</p>
        <p>Other causes of hyperkalemia:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic kidney disease, especially when secondary to diabetes, is the most commonly identified cause of hyperkalemia.</p>
          </list-item>
          <list-item>
            <p>When renal function is normal, consider the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Hypoaldosteronism or acquired renal tubular acidosis (type 4), particularly in the setting of marked volume depletion</p>
              </list-item>
              <list-item>
                <p>Medication effects. Examples include potassium-sparing diuretics (e.g., spironolactone), nonsteroidal anti-inflammatory drugs (NSAIDs), angiotensin inhibitors, trimethoprim, and cyclosporine.</p>
              </list-item>
              <list-item>
                <p>Primary adrenal insufficiency or deficiency of an adrenal synthetic enzyme</p>
              </list-item>
            </list>
          </list-item>
        </list>
      </sec>
      <sec id="pha2.Management">
        <title>Management</title>
        <sec id="pha2.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with pseudohypoaldosteronism type II (PHAII), the following evaluations are recommended, if not performed as part of the diagnostic evaluation:</p>
          <list list-type="bullet">
            <list-item>
              <p>Serum electrolyte analysis</p>
            </list-item>
            <list-item>
              <p>Noninvasive blood pressure measurement</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="pha2.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Electrolyte and blood pressure abnormalities of PHAII are often corrected with thiazide diuretics. Metabolic abnormalities and hypertension generally improve within one week.</p>
          <p>Different thiazide diuretics exist, with different dosing regimens. In general dosing is titrated to normalization of blood pressure. It is possible that dosing may need to be increased over time or that additional anti-hypertensives may be required to adequately control blood pressure.</p>
          <p>There are no established guidelines regarding age at which treatment should begin for individuals with PHAII, but affected children who have hypertension are generally treated.</p>
        </sec>
        <sec id="pha2.Prevention_of_Primary_Manifestation">
          <title>Prevention of Primary Manifestations</title>
          <p>See <xref ref-type="sec" rid="pha2.Treatment_of_Manifestations">Treatment of Manifestations</xref>.</p>
        </sec>
        <sec id="pha2.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Control of blood pressure is important to reduce the risk for cardiovascular and renal disease and stroke.</p>
        </sec>
        <sec id="pha2.Surveillance">
          <title>Surveillance</title>
          <p>Appropriate surveillance includes routine electrolyte and blood pressure measurements, monitored in the same manner as for any person treated with a thiazide diuretic.</p>
        </sec>
        <sec id="pha2.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Untreated individuals with PHAII should avoid excessive intake of foods high in salt and potassium as these may exacerbate hypertension and hyperkalemia.</p>
        </sec>
        <sec id="pha2.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate apparently asymptomatic older and younger at-risk relatives of an affected individual in order to identify as early as possible those who would benefit from prompt initiation of treatment. Evaluations can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of serum potassium concentration and blood pressure;</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing if the pathogenic variant(s) in the family is known.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="pha2.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="pha2.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>During the pregnancy of a woman with PHAII, electrolytes and blood pressure should be monitored regularly and blood pressure medication adjusted as needed.</p>
          <p>Some antihypertensive medications (including thiazide diuretics) have been associated with adverse fetal outcome, especially when taken during the first trimester of pregnancy. The best time to discuss the risk to the fetus associated with a maternal medication is prior to conception. Women with PHAII who become pregnant should be referred to an obstetrics group with expertise in high risk pregnancies.</p>
          <p>To access further information on medication use in pregnancy, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mothertobaby.org">www.mothertobaby.org</ext-link>.</p>
        </sec>
        <sec id="pha2.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="pha2.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="pha2.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Pseudohypoaldosteronism type II (PHAII) is most commonly inherited in an autosomal dominant manner. PHAIID can also be inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="pha2.Risk_to_Family_Members__Autosomal_D">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals diagnosed with PHAII have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with PHAII may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant [<xref ref-type="bibr" rid="pha2.REF.gong.2008.230">Gong et al 2008</xref>].</p>
              <p>Fifteen of 182 reported cases have been <italic toggle="yes">de novo</italic>; 14/15 caused by a heterozygous pathogenic <italic toggle="yes">CUL3</italic> variant and 1/15 caused by a heterozygous <italic toggle="yes">KLHL3</italic> pathogenic variant [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>, <xref ref-type="bibr" rid="pha2.REF.tsuji.2013.166">Tsuji et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.picard.2015a.e79">Picard et al 2015a</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include clinical evaluation (electrolyte analysis and blood pressure measurement) and/or molecular genetic testing if a <italic toggle="yes">CUL3</italic>, <italic toggle="yes">KLHL3</italic>, <italic toggle="yes">WNK1</italic>, or <italic toggle="yes">WNK4</italic> pathogenic variant has been identified in the proband.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent (although no instances of germline mosaicism have been reported, it remains a possibility).</p>
            </list-item>
            <list-item>
              <p>Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure to recognize the syndrome as a result of a milder phenotypic presentation, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents: if a parent of the proband is affected or has a pathogenic variant, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low. However, the sibs of a proband with clinically unaffected parents are still at increased risk for PHAII because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with PHAII has a 50% chance of inheriting the <italic toggle="yes">CUL3</italic>, <italic toggle="yes">KLHL3</italic>, <italic toggle="yes">WNK1</italic>, or <italic toggle="yes">WNK4</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected or has a pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="pha2.Risk_to_Family_Members__Autosomal_R">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">KLHL3</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Carriers of a <italic toggle="yes">KLHL3</italic> pathogenic variant associated with autosomal recessive PHAIID are typically asymptomatic and do not appear to be at risk of developing the disorder; however, thorough clinical analysis of such individuals over time has not been reported.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Carriers of a <italic toggle="yes">KLHL3</italic> pathogenic variant associated with autosomal recessive PHAIID are typically asymptomatic and are not thought to be at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with autosomal recessive PHAIID are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">KLHL3</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">KLHL3</italic> pathogenic variant.</p>
          <p><bold>Carrier (heterozygote) detection.</bold> Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">KLHL3</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="pha2.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="pha2.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="pha2.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Once the <italic toggle="yes">CUL3</italic>, <italic toggle="yes">KLHL3</italic>, <italic toggle="yes">WNK1</italic>, or <italic toggle="yes">WNK4</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for PHAII are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although decisions regarding prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="pha2.Resources">
        <title>Resources</title>
      </sec>
      <sec id="pha2.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="pha2.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Pathogenic variants in the genes encoding two members of the WNK protein family of serine-threonine kinases, <italic toggle="yes">WNK1</italic> and <italic toggle="yes">WNK4</italic>, have been implicated in the pathogenesis of pseudohypoaldosteronism type II (PHAII) [<xref ref-type="bibr" rid="pha2.REF.wilson.2001.1107">Wilson et al 2001</xref>]. Members of this kinase family are named WNK (or <italic toggle="yes">w</italic>ith <italic toggle="yes">n</italic>o lysine [<italic toggle="yes">K</italic>]) kinases because of their unique substitution of cysteine for lysine at a highly conserved residue within the catalytic kinase domain [<xref ref-type="bibr" rid="pha2.REF.xu.2000.16795">Xu et al 2000</xref>]. Over the past decade, members of the WNK kinase family have been shown to regulate the coordinated transport of Na<sup>+</sup>, K<sup>+</sup>, and Cl<sup>-</sup> ions across epithelia in a variety of tissues [<xref ref-type="bibr" rid="pha2.REF.kahle.2008.91">Kahle et al 2008</xref>].</p>
          <p>Alterations in <italic toggle="yes">WNK1</italic> and <italic toggle="yes">WNK4</italic> are present in only a minority of individuals with PHAII, motivating the search for additional genetic contributions to the disorder in other families. Recently, pathogenic variants in kelch-like 3 (<italic toggle="yes">KLHL3</italic>) and cullin 3 (<italic toggle="yes">CUL3</italic>) have been identified in the majority of families with PHAII [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>, <xref ref-type="bibr" rid="pha2.REF.louisditpicard.2012">Louis-Dit-Picard et al 2012</xref>]. The protein products of <italic toggle="yes">CUL3</italic> and <italic toggle="yes">KLHL3</italic> function together as part of the cullin-RING E3 ubiquitin ligase complex, which has a role in ubiquitin-mediated protein degradation.</p>
          <p>The electrolyte and blood pressure abnormalities in individuals with PHAII are readily corrected with thiazide diuretics, inhibitors of the Na-Cl cotransporter (NCC; encoded by <italic toggle="yes">SLC12A3</italic>) expressed in the renal distal convoluted and connecting tubules (see Management, <xref ref-type="sec" rid="pha2.Treatment_of_Manifestations">Treatment of Manifestations</xref>). This clinical observation led to the initial hypothesis that increased activity of NCC could play a role in the pathogenesis of PHAII [<xref ref-type="bibr" rid="pha2.REF.gordon.1986.93">Gordon 1986</xref>]. However, to date, no PHAII-causing variants in the gene encoding NCC have been demonstrated.</p>
          <sec id="pha2.CUL3">
            <title>
              <italic toggle="yes">CUL3</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CUL3</italic> is widely expressed and has several alternatively spliced isoforms. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pha2" object-id="pha2.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold>
<italic toggle="yes">CUL3</italic> alterations causing PHAII occur within intron 8, exon 9, or intron 9 and disrupt splicing of exon 9. This results in a 57-amino acid in-frame deletion.</p>
            <p><bold>Normal gene product.</bold> CUL3 is a component of the cullin-RING E3 ubiquitin ligase complex, which functions in ubiquitin-mediated proteolysis. Immunostaining of mouse kidney demonstrates that CUL3 is present throughout the nephron [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>].</p>
            <p><bold>Abnormal gene product.</bold> It has been suggested that <italic toggle="yes">CUL3</italic> pathogenic variants in PHAII may disrupt ubiquitination of at least a subset of KLHL3 targets [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>]. The observation that all reported <italic toggle="yes">CUL3</italic> pathogenic variants impair splicing of exon 9 and result in an in-frame deletion of a segment of <italic toggle="yes">CUL3</italic> may hint at the functional specificity of these pathogenic variants [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>].</p>
          </sec>
          <sec id="pha2.KLHL3">
            <title>
              <italic toggle="yes">KLHL3</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KLHL3</italic> is widely expressed with at least three alternatively spliced isoforms reported. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pha2" object-id="pha2.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Dominant <italic toggle="yes">KLHL3</italic> pathogenic variants that cause PHAII are missense alternations that cluster in segments connecting beta-strands of Kelch propeller blades within the C-terminal Kelch propeller domain and disrupt substrate binding.</p>
            <p>Recessive <italic toggle="yes">KLHL3</italic> pathogenic variants occur throughout the gene and include frameshift and premature termination variants.</p>
            <p><bold>Normal gene product.</bold> KLHL3 is a component of the cullin-RING E3 ubiquitin ligase complex, which functions in ubiquitin-mediated proteolysis. KLHL3 contains an N-terminal bric-a-brac tramtrack broad complex (BTB) domain that has a role in binding to CUL3 and a BTB and C-terminal Kelch (BACK) domain. KLHL3 also contains a C-terminal six-bladed Kelch propeller domain that functions in substrate binding.</p>
            <p>Wild-type KLHL3 has been shown to bind to WNK4 and WNK1 [<xref ref-type="bibr" rid="pha2.REF.ohta.2013.111">Ohta et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.shibata.2013.7838">Shibata et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.wakabayashi.2013.858">Wakabayashi et al 2013</xref>]. Furthermore, binding of KLHL3 to WNK4 has been shown to result in ubiquitination and degradation of WNK4 in vitro, suggesting that KLHL3 normally regulates WNK4 levels via ubiquitin-mediated proteolysis [<xref ref-type="bibr" rid="pha2.REF.shibata.2013.7838">Shibata et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.wakabayashi.2013.858">Wakabayashi et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.wu.2013.1717">Wu &#x00026; Peng 2013</xref>]. Expression of KLHL3 together with binding of KLHL3 to WNK1 has also been shown to result in ubiquitination of WNK1 [<xref ref-type="bibr" rid="pha2.REF.ohta.2013.111">Ohta et al 2013</xref>].</p>
            <p>Immunostaining of mouse kidney demonstrates that KLHL3 is predominantly present in the distal convoluted tubule and collecting duct [<xref ref-type="bibr" rid="pha2.REF.boyden.2012.98">Boyden et al 2012</xref>, <xref ref-type="bibr" rid="pha2.REF.louisditpicard.2012">Louis-Dit-Picard et al 2012</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Missense variants in <italic toggle="yes">KLHL3</italic> that cause PHAII disrupt binding to WNK4, WNK1, or CUL3 and lead to decreased ubiquitination and increased levels of WNK4 [<xref ref-type="bibr" rid="pha2.REF.mori.2013.30">Mori et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.ohta.2013.111">Ohta et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.shibata.2013.7838">Shibata et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.wakabayashi.2013.858">Wakabayashi et al 2013</xref>]. Mutated KLHL3 has also been shown to decrease WNK4-mediated clearance of ROMK from the cell membrane [<xref ref-type="bibr" rid="pha2.REF.shibata.2013.7838">Shibata et al 2013</xref>].</p>
          </sec>
          <sec id="pha2.WNK1">
            <title>
              <italic toggle="yes">WNK1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">WNK1</italic> transcript variant 1 (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_018979.3">NM_018979.3</ext-link>) has 30 exons and encodes the most common protein isoform. Alternatively spliced transcript variants have been described; the full-length nature of all of them has yet to be determined. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pha2" object-id="pha2.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Pathogenic variants in <italic toggle="yes">WNK1</italic> were initially reported in two families with PHAII [<xref ref-type="bibr" rid="pha2.REF.wilson.2001.1107">Wilson et al 2001</xref>]. Both are large deletions (41 kb and 21 kb) that occur within the 60-kb intron 1 of <italic toggle="yes">WNK1</italic>. The deletions do not affect the coding sequence of the flanking exons. Recently, 6 kindreds (9 individuals) were reported to have pathogenic missense variants in <italic toggle="yes">WNK1</italic>, coupled with a phenotype that includes hyperkalemia and acidosis; the hypertension was minimal. The pathogenic missense variants clustered in the region homologous to the acidic domain mutated in <italic toggle="yes">WNK4</italic> [<xref ref-type="bibr" rid="pha2.REF.picard.2015b.e1">Picard et al 2015b</xref>].</p>
            <table-wrap id="pha2.T.selected_wnk1_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Selected <italic toggle="yes">WNK1</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_pha2.T.selected_wnk1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_pha2.T.selected_wnk1_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_pha2.T.selected_wnk1_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">g.18538_59810del&#x000a0;<sup>1,2</sup></td>
                    <td headers="hd_h_pha2.T.selected_wnk1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 3</td>
                    <td headers="hd_h_pha2.T.selected_wnk1_pathogenic_variants_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NG_007984.2">NG_007984.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">g.28500_50277del&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_pha2.T.selected_wnk1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 3</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the author.&#x000a0;<italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic>&#x000a0;follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="pha2.TF.2.1">
                  <label>1. </label>
                  <p>Deletion within intron 1 (also known as NG_007984.2:c.759+12272_760-5774del)</p>
                </fn>
                <fn id="pha2.TF.2.2">
                  <label>2. </label>
                  <p>
                    <xref ref-type="bibr" rid="pha2.REF.wilson.2001.1107">Wilson et al [2001]</xref>
                  </p>
                </fn>
                <fn id="pha2.TF.2.3">
                  <label>3. </label>
                  <p>No amino acid change is expected.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">WNK1</italic> encodes at least four different alternatively spliced <italic toggle="yes">WNK1</italic> transcripts (See see <related-object source-id="gene" document-id="pha2" object-id="pha2.molgen.TA">Table A</related-object>, <bold>Gene</bold> further details). The interplay between these isoforms is complex. Two variants were initially identified: a longer isoform with ubiquitous tissue expression (L-WNK1) and a smaller isoform that lacks the 5&#x02019; kinase domain of the larger isoform and appears to be kidney-specific (KS-WNK1) [<xref ref-type="bibr" rid="pha2.REF.delaloy.2003.9208">Delaloy et al 2003</xref>, <xref ref-type="bibr" rid="pha2.REF.o_reilly.2003.2447">O&#x02019;Reilly et al 2003</xref>]. A neuronal isoform of WNK1 (termed WNK1/HSN2) that is highly expressed in the cell body of sensory ganglia neurons and neuronal projections has been identified. Pathogenic variants in an alternatively spliced exon of the transcript that encodes this isoform cause autosomal recessive <related-object link-type="booklink" source-id="gene" document-id="hsan2" document-type="chapter">hereditary sensory and autonomic neuropathy type 2</related-object>, a disorder of progressive sensory deficit to touch, temperature, and pain [<xref ref-type="bibr" rid="pha2.REF.shekarabi.2008.2496">Shekarabi et al 2008</xref>].</p>
            <p>The L-Wnk1 isoform can activate the kinase SPAK (encoded by <italic toggle="yes">STK39</italic>), which in turn can phosphorylate and activate NCC (the Na-Cl cotransporter) encoded by <italic toggle="yes">SLC12A3</italic>. The KS-WNK1 isoform, expressed predominantly along the distal nephron, binds to and inhibits the activity of L-Wnk1 in <italic toggle="yes">Xenopus</italic> [<xref ref-type="bibr" rid="pha2.REF.subramanya.2006.f619">Subramanya et al 2006</xref>] and transgenic mice [<xref ref-type="bibr" rid="pha2.REF.liu.2011.855">Liu et al 2011</xref>]. WNK1 can also interact, through a conserved &#x02018;HQ&#x02019; domain, with other WNK kinases, including WNK4. These interactions have complex functional effects [<xref ref-type="bibr" rid="pha2.REF.yang.2003.1039">Yang et al 2003</xref>, <xref ref-type="bibr" rid="pha2.REF.ch_vezcanales.2014.1047">Ch&#x000e1;vez-Canales et al 2014</xref>].</p>
            <p>As a multifunctional regulator of ion channels and transporters, WNK1 also inhibits the K<sup>+</sup> channel ROMK1, encoded by <italic toggle="yes">KCNJ1</italic> [<xref ref-type="bibr" rid="pha2.REF.liu.2009.12198">Liu et al 2009</xref>] and (probably via phosphorylation of downstream kinase SGK-1) activates the amiloride-sensitive Na<sup>+</sup> channel ENaC encoded by <italic toggle="yes">SCNN1A</italic>, <italic toggle="yes">SCNN1B</italic>, and <italic toggle="yes">SCNN1G</italic> [<xref ref-type="bibr" rid="pha2.REF.xu.2005.10315">Xu et al 2005</xref>, <xref ref-type="bibr" rid="pha2.REF.hadchouel.2010.18109">Hadchouel et al 2010</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Both of the known <italic toggle="yes">WNK1</italic> deletions causing PHAII occur within the first intron of the gene and do not affect the amino acid structure of the gene product(s). It was initially shown that deletion within the first intron increases <italic toggle="yes">WNK1</italic> transcription in peripheral leukocytes [<xref ref-type="bibr" rid="pha2.REF.wilson.2001.1107">Wilson et al 2001</xref>]. Subsequent work demonstrated that the intron deletion leads to increased L-WNK1 expression in the distal convoluted tubule [<xref ref-type="bibr" rid="pha2.REF.vidalpetiot.2013.14366">Vidal-Petiot et al 2013</xref>]. These findings support the hypothesis that the deletion within the first intron leads to increased expression of L-WNK1, which should phosphorylate and stimulate NCC.</p>
            <p>A knockout mouse model of L-WNK1 has also been generated, and mice with a heterozygous targeted disruption of the L-<italic toggle="yes">Wnk1</italic> transcript have significantly decreased blood pressure compared to wild type [<xref ref-type="bibr" rid="pha2.REF.zambrowicz.2003.14109">Zambrowicz et al 2003</xref>]. Mice with targeted disruption of KS<italic toggle="yes">-Wnk1</italic> exhibited increased activity of NCC, altered function of the ROMK (encoded by <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6255"><italic toggle="yes">KCNJ1</italic></ext-link>) and BKCa potassium channels, and decreased ENaC expression [<xref ref-type="bibr" rid="pha2.REF.hadchouel.2010.18109">Hadchouel et al 2010</xref>], confirming previous in vitro observations.</p>
          </sec>
          <sec id="pha2.WNK4">
            <title>
              <italic toggle="yes">WNK4</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">WNK4</italic> has 19 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pha2" object-id="pha2.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> All reported pathogenic variants are missense alterations. All pathogenic variants reported to date have been identified in exons 7 and 17 [<xref ref-type="bibr" rid="pha2.REF.wilson.2001.1107">Wilson et al 2001</xref>, <xref ref-type="bibr" rid="pha2.REF.golbang.2005.295">Golbang et al 2005</xref>, <xref ref-type="bibr" rid="pha2.REF.brooks.2012.791">Brooks et al 2012</xref>].</p>
            <table-wrap id="pha2.T.selected_wnk4_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p>Selected <italic toggle="yes">WNK4</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1679A&#x0003e;G</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu560Gly</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_3" rowspan="8" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_032387.4">NM_032387.4</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_115763.2">NP_115763.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1682C&#x0003e;T</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro561Leu</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1684G&#x0003e;A</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu562Lys</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1690G&#x0003e;C</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp564His</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1691A&#x0003e;C</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp564Ala</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1693C&#x0003e;G</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln565Glu</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3505A&#x0003e;G</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys1169Glu</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3553C&#x0003e;T</td>
                    <td headers="hd_h_pha2.T.selected_wnk4_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1185Cys</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors.&#x000a0;<italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic>&#x000a0;follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">WNK4</italic> product is a 1243-amino acid protein encoded by a 3732-nucleotide open reading frame within a 4-kb cDNA transcript. Northern blot analysis showed expression primarily within the kidney, but immunofluorescence studies have shown the protein is present in the epithelial lining of a variety of tissues including the colon, liver, and pancreas [<xref ref-type="bibr" rid="pha2.REF.kahle.2004a.2064">Kahle et al 2004a</xref>].</p>
            <p>WNK4 has been shown to regulate the activity of a number of ion transporters through heterologous expression in <italic toggle="yes">Xenopus</italic> oocytes and in mammalian cell systems [<xref ref-type="bibr" rid="pha2.REF.kahle.2008.91">Kahle et al 2008</xref>]. The major effect of WNK4 in vivo appears to be stimulation of NCC; it may also inhibit ROMK [<xref ref-type="bibr" rid="pha2.REF.kahle.2003.372">Kahle et al 2003</xref>, <xref ref-type="bibr" rid="pha2.REF.wilson.2003.680">Wilson et al 2003</xref>]. WNK4 has also been reported to increase paracellular chloride permeability in mammalian kidney cells via claudin phosphorylation [<xref ref-type="bibr" rid="pha2.REF.kahle.2004b.14877">Kahle et al 2004b</xref>, <xref ref-type="bibr" rid="pha2.REF.yamauchi.2004.4690">Yamauchi et al 2004</xref>, <xref ref-type="bibr" rid="pha2.REF.tatum.2007.3887">Tatum et al 2007</xref>]. Like WNK1, WNK4 also regulates other structurally diverse but functionally related ion channels including ENaC [<xref ref-type="bibr" rid="pha2.REF.ring.2007a.4020">Ring et al 2007a</xref>, <xref ref-type="bibr" rid="pha2.REF.ring.2007b.4025">Ring et al 2007b</xref>] and the cation nonselective TRP channels TRPV4 and TRPV5 [<xref ref-type="bibr" rid="pha2.REF.fu.2006.f1305">Fu et al 2006</xref>]. Deletion of WNK4 results in a phenotype that resembles Gitelman syndrome, indicating that the predominant WNK4 effect in vivo is stimulation of NCC [<xref ref-type="bibr" rid="pha2.REF.casta_edabueno.2012.7929">Casta&#x000f1;eda-Bueno et al 2012</xref>, <xref ref-type="bibr" rid="pha2.REF.takahashi.2014">Takahashi et al 2014</xref>].</p>
            <p><bold>Abnormal gene product.</bold> The effects of PHAII-associated <italic toggle="yes">WNK4</italic> pathogenic variants on the above targets have been evaluated in vitro in oocytes and mammalian cells and in vivo in mouse models [reviewed in <xref ref-type="bibr" rid="pha2.REF.ch_vezcanales.2014.1047">Ch&#x000e1;vez-Canales et al 2014</xref>].</p>
            <p>Important information about the mechanisms underlying <italic toggle="yes">WNK4</italic>-related PHAII came from the development and characterization of mouse models of PHAII [<xref ref-type="bibr" rid="pha2.REF.lalioti.2006.1124">Lalioti et al 2006</xref>, <xref ref-type="bibr" rid="pha2.REF.yang.2007.331">Yang et al 2007</xref>]. Mice transgenic for a chromosomal segment encoding the murine <italic toggle="yes">Wnk4</italic> with a Gln562Glu pathogenic variant (orthologous to the human p.Gln565Glu pathogenic variant) had hyperkalemia, higher blood pressure, and hypercalciuria compared to mice transgenic for a chromosomal segment encoding wild-type <italic toggle="yes">Wnk4</italic> [<xref ref-type="bibr" rid="pha2.REF.lalioti.2006.1124">Lalioti et al 2006</xref>]. In addition, marked hyperplasia of the distal convoluted tubule (DCT) and increased expression of NCC were noted in mutated <italic toggle="yes">Wnk4</italic> transgenic mice but not in wild-type <italic toggle="yes">Wnk4</italic> transgenic mice. All abnormalities were entirely corrected when mutated <italic toggle="yes">Wnk4</italic> transgenic mice were crossed with mice harboring a targeted disruption of the gene encoding NCC, indicating that the effect of mutated <italic toggle="yes">Wnk4</italic> on NCC activity alone is sufficient to cause the PHAII phenotype. Essentially similar findings were reported in a mouse <italic toggle="yes">Wnk4</italic> mutated knock-in model of PHAII [<xref ref-type="bibr" rid="pha2.REF.yang.2007.331">Yang et al 2007</xref>].</p>
            <p>Most PHAII-causing variants in WNK4 cluster within a highly conserved non-catalytic domain just distal to the kinase domain. Recent in vitro studies have demonstrated that this segment is critical for binding to KLHL3, and PHAII-associated variants within this domain disrupt interactions between WNK4 and KLHL3 [<xref ref-type="bibr" rid="pha2.REF.ohta.2013.111">Ohta et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.shibata.2013.7838">Shibata et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.wakabayashi.2013.858">Wakabayashi et al 2013</xref>]. Due to the role of KLHL3 in ubiquitin-mediated proteolysis (discussed <xref ref-type="sec" rid="pha2.KLHL3">above</xref>), this should lead to increased WNK4 levels. Indeed, increased WNK4 levels are reported in the WNK4 mouse models of PHAII discussed above [<xref ref-type="bibr" rid="pha2.REF.shibata.2013.7838">Shibata et al 2013</xref>, <xref ref-type="bibr" rid="pha2.REF.wakabayashi.2013.858">Wakabayashi et al 2013</xref>].</p>
            <p>It has also been suggested that pathogenic variants within this segment disrupt a calcium-sensing mechanism important in the regulation of WNK4 kinase activity [<xref ref-type="bibr" rid="pha2.REF.na.2012.293">Na et al 2012</xref>]. Similarly, the PHAII-associated p.Arg1185Cys pathogenic variant (located near the C-terminus of WNK4 and separate from this domain) has also been implicated in impaired calcium sensing and altered phosphorylation by SGK1 [<xref ref-type="bibr" rid="pha2.REF.na.2013.f8">Na et al 2013</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="pha2.References">
        <title>References</title>
        <sec id="pha2.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="pha2.Literature_Cited.reflist0">
            <ref id="pha2.REF.boyden.2012.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boyden</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choate</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson-Williams</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farhi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toka</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tikhonova</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjornson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mane</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colussi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semmekrot</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poujol</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valimaki</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Ferrari</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanjad</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutkin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karet</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucci</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockigt</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keppler-Noreuil</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anand</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whiteford</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dewar</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bettinelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadrowski</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belsha</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunley</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trachtman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>TRP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinsk</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bockenhauer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shenoy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaidyanathan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foreman</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasoulpour</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thameem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Shahrouri</surname>
                    <given-names>HZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radhakrishnan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gharavi</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goilav</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.</article-title>
                <source>Nature</source>
                <volume>482</volume>
                <fpage>98</fpage>
                <lpage>102</lpage>
                <pub-id pub-id-type="pmid">22266938</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.brooks.2012.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sayer</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salzmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaidya</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene.</article-title>
                <source>QJM</source>
                <year>2012</year>
                <volume>105</volume>
                <fpage>791</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">21764813</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.casta_edabueno.2012.7929">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Casta&#x000f1;eda-Bueno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cervantes-P&#x000e9;rez</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>V&#x000e1;zquez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uribe</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kantesaria</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morla</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bobadilla</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doucet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alessi</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gamba</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2012</year>
                <volume>109</volume>
                <fpage>7929</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">22550170</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.ch_vezcanales.2014.1047">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ch&#x000e1;vez-Canales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soukaseum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreno</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacheco-Alvarez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidal-Petiot</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casta&#x000f1;eda-Bueno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>V&#x000e1;zquez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rojas-Vega</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meermeier</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellison</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gamba</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadchouel</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.</article-title>
                <source>Hypertension.</source>
                <year>2014</year>
                <volume>64</volume>
                <fpage>1047</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">25113964</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.delaloy.2003.9208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delaloy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houot</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Disse-Nicodeme</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasc</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corvol</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform.</article-title>
                <source>Mol Cell Biol</source>
                <volume>23</volume>
                <fpage>9208</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">14645531</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.farfel.2011.1547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farfel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melnikov</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holtzman</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinhas-Hamiel</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farfel</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Effect of age and affection status on blood pressure, serum potassium and stature in familial hyperkalaemia and hypertension.</article-title>
                <source>Nephrol Dial Transplant</source>
                <volume>26</volume>
                <fpage>1547</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">20956807</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.fu.2006.f1305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subramanya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozansky</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>WNK kinases influence TRPV4 channel function and localization.</article-title>
                <source>Am J Physiol Renal Physiol</source>
                <volume>290</volume>
                <fpage>F1305</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">16403833</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.glover.2014.721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Glover</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ware</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henry</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wain</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van&#x02019;t Hoff</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobin</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>IP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stowasser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Shaughnessy</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Detection of mutations in KLHL3 and CUL3 in families with familial hyperkalaemic hypertension (FHHt or Gordon syndrome).</article-title>
                <source>Clin Sci (Lond)</source>
                <volume>126</volume>
                <fpage>721</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24266877</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.golbang.2005.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Golbang</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murthy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cope</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van't Hoff</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuthbert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Shaughnessy</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <article-title>A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D&#x0003e;H) in the acidic motif of the WNK4 gene.</article-title>
                <source>Hypertension.</source>
                <year>2005</year>
                <volume>46</volume>
                <fpage>295</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">15998707</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.gong.2008.230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gong</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cui</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ning</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene.</article-title>
                <source>Endocrine</source>
                <volume>33</volume>
                <fpage>230</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19016006</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.gordon.1986.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>RD</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate.</article-title>
                <source>Hypertension</source>
                <volume>8</volume>
                <fpage>93</fpage>
                <lpage>102</lpage>
                <pub-id pub-id-type="pmid">3002982</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.hadchouel.2010.18109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hadchouel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soukaseum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;sst</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>XO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baudrie</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fc;rrer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cambillau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elghozi</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loffing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>107</volume>
                <fpage>18109</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">20921400</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.kahle.2004a.2064">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forbush</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aronson</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>101</volume>
                <fpage>2064</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14769928</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.kahle.2004b.14877">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macgregor</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hoek</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ardito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kashgarian</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giebisch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulpaep</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Paracellular Cl- permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>101</volume>
                <fpage>14877</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">15465913</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.kahle.2008.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinehart</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giebisch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gamba</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel protein kinase signaling pathway essential for blood pressure regulation in humans.</article-title>
                <source>Trends Endocrinol Metab</source>
                <volume>19</volume>
                <fpage>91</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18280177</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.kahle.2003.372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leng</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalioti</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Connell</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapson</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacGregor</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giebisch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion.</article-title>
                <source>Nat Genet</source>
                <volume>35</volume>
                <fpage>372</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14608358</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.lalioti.2006.1124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lalioti</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volkman</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toka</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson-Williams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellison</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flavell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booth</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geller</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>WNK4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>1124</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">16964266</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.liu.2009.12198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase.</article-title>
                <source>J Biol Chem</source>
                <volume>284</volume>
                <fpage>12198</fpage>
                <lpage>206</lpage>
                <pub-id pub-id-type="pmid">19244242</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.liu.2011.855">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Truong</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auchus</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>(Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>20</volume>
                <fpage>855</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">21131289</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.louisditpicard.2012">
              <mixed-citation publication-type="other">Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M; International Consortium for Blood Pressure (ICBP), Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott JJ, Jeunemaitre X. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet. 2012;44:456-60, S1-3.</mixed-citation>
            </ref>
            <ref id="pha2.REF.mansfield.1997.202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mansfield</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farfel</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucci</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutkin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vialettes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christofilis</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauppinen-Makelin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21.</article-title>
                <source>Nat Genet</source>
                <volume>16</volume>
                <fpage>202</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9171836</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.mayan.2004.4025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mayan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munter</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaharabany</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouallem</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauzner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holtzman</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farfel</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>89</volume>
                <fpage>4025</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15292344</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.mitani.2016.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mitani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furuichi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narumi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiga</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>A patient with pseudohypoaldosteronism type II complicated by congenital hypopituitarism carrying a KLHL3 mutation.</article-title>
                <source>Clin Pediatr Endocrinol.</source>
                <year>2016</year>
                <volume>25</volume>
                <fpage>127</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">27780982</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.mori.2013.30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakabayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through different molecular mechanisms.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>439</volume>
                <fpage>30</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23962426</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.na.2012.293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Na</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Disease-causing mutations in the acidic motif of WNK4 impair the sensitivity of WNK4 kinase to calcium ions.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>419</volume>
                <fpage>293</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22342722</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.na.2013.f8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Na</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dong</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Disease-causing R1185C mutation of WNK4 disrupts a regulatory mechanism involving calmodulin binding and SGK1 phosphorylation sites.</article-title>
                <source>Am J Physiol Renal Physiol.</source>
                <volume>304</volume>
                <fpage>F8</fpage>
                <lpage>F18</lpage>
                <pub-id pub-id-type="pmid">23054253</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.ohta.2013.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schumacher</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehellou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knebel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macartney</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alessi</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurz</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>The CUL3-KLHL3 E3 ligase complex mutated in Gordon&#x02019;s hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.</article-title>
                <source>Biochem J.</source>
                <volume>451</volume>
                <fpage>111</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">23387299</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.o_reilly.2003.2447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O&#x02019;Reilly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speirs</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain.</article-title>
                <source>J Am Soc Nephrol</source>
                <volume>14</volume>
                <fpage>2447</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">14514722</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.picard.2015a.e79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latreche</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thurairajasingam</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auzan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiquet</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frayssinet</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garnier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jendruchova</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobbedez</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martorell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pela</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taque</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas-Poussou</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <article-title>6C.01: CULLIN-3 mutations leading to skipping of exon 9 are responsible for severe cases of familial hyperkalaemic hypertension.</article-title>
                <source>J Hypertens.</source>
                <year>2015a</year>
                <volume>33</volume>
                <supplement>Suppl 1</supplement>
                <fpage>e79</fpage>
                <pub-id pub-id-type="pmid">26102933</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.picard.2015b.e1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thurairajasingam</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Decramer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girerd</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oshaugnessy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulatero</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roussey</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tack</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unwin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas-Poussou</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <article-title>1A.01: mutations affecting the conserved acidic motif of WNK1 cause inherited normotensive hyperkalemic acidosis.</article-title>
                <source>J Hypertens.</source>
                <year>2015b</year>
                <volume>33</volume>
                <supplement>Suppl 1</supplement>
                <fpage>e1</fpage>
                <pub-id pub-id-type="pmid">26102642</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.ring.2007a.4020">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ring</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>SX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leng</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinehart</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalioti</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volkman</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2007a</year>
                <article-title>WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>104</volume>
                <fpage>4020</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17360470</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.ring.2007b.4025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ring</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leng</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinehart</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2007b</year>
                <article-title>An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>104</volume>
                <fpage>4025</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17360471</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.schambelan.1981.716">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schambelan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebastian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rector</surname>
                    <given-names>FC</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.</article-title>
                <source>Kidney Int</source>
                <volume>19</volume>
                <fpage>716</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">7026872</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.shekarabi.2008.2496">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shekarabi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivi&#x000e8;re</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dion</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toulouse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lafreni&#x000e8;re</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vercauteren</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hince</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laganiere</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rochefort</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II.</article-title>
                <source>J Clin Invest.</source>
                <volume>118</volume>
                <fpage>2496</fpage>
                <lpage>505</lpage>
                <pub-id pub-id-type="pmid">18521183</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.shibata.2013.7838">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shibata</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puthumana</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>110</volume>
                <fpage>7838</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">23576762</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.subramanya.2006.f619">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Subramanya</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellison</surname>
                    <given-names>DH</given-names>
                  </name>
                </person-group>
                <article-title>Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform.</article-title>
                <source>Am J Physiol Renal Physiol.</source>
                <year>2006</year>
                <volume>290</volume>
                <fpage>F619</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">16204408</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.takahashi.2014">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeniya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>WNK4 is the major WNK positively regulating NCC in the mouse kidney.</article-title>
                <source>Biosci Rep.</source>
                <year>2014</year>
                <volume>34</volume>
                <issue>3</issue>
                <pub-id pub-id-type="pmid">24655003</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.tatum.2007.3887">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tatum</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeansonne</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YH</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>WNK4 phosphorylates ser(206) of claudin-7 and promotes paracellular Cl(-) permeability.</article-title>
                <source>FEBS Lett.</source>
                <volume>581</volume>
                <fpage>3887</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">17651736</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.tsuji.2013.166">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unishi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takewa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isobe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiga</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3.</article-title>
                <source>BMC Nephrol.</source>
                <year>2013</year>
                <month>Jul</month>
                <day>31</day>
                <volume>14</volume>
                <fpage>166</fpage>
                <pub-id pub-id-type="pmid">23902721</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.vidalpetiot.2013.14366">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vidal-Petiot</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elvira-Matelot</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutig</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soukaseum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baudrie</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheval</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huc</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cambillau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bachmann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doucet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadchouel</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>WNK1-related familial hyperkalemic hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>110</volume>
                <fpage>14366</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">23940364</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.wakabayashi.2013.858">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wakabayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isobe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiga</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikuchi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawaguchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonoyama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension.</article-title>
                <source>Cell Rep.</source>
                <volume>3</volume>
                <fpage>858</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">23453970</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.wilson.2001.1107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Disse-Nicod&#x000e8;me</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choate</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson-Williams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desitter</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milford</surname>
                    <given-names>DV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipkin</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Achard</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feely</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dussol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berland</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unwin</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farfel</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Human hypertension caused by mutations in WNK kinases.</article-title>
                <source>Science.</source>
                <volume>293</volume>
                <fpage>1107</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">11498583</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.wilson.2003.680">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabath</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalioti</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapson</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoover</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gamba</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lifton</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>100</volume>
                <fpage>680</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12515852</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.wu.2013.1717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.</article-title>
                <source>FEBS Lett.</source>
                <volume>587</volume>
                <fpage>1717</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">23665031</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.xu.2000.16795">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>English</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilsbacher</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stippec</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldsmith</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobb</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.</article-title>
                <source>J Biol Chem.</source>
                <volume>275</volume>
                <fpage>16795</fpage>
                <lpage>801</lpage>
                <pub-id pub-id-type="pmid">10828064</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.xu.2005.10315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stippec</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazrak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>XJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>English</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortega</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobb</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>WNK1 activates SGK1 to regulate the epithelial sodium channel.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>102</volume>
                <fpage>10315</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">16006511</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.yamauchi.2004.4690">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamauchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>101</volume>
                <fpage>4690</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15070779</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.yang.2003.1039">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellison</surname>
                    <given-names>DH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>WNK kinases regulate thiazide-sensitive Na-Cl cotransport.</article-title>
                <source>J Clin Invest.</source>
                <volume>111</volume>
                <fpage>1039</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">12671053</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.yang.2007.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiga</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriguchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibuya</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.</article-title>
                <source>Cell Metab.</source>
                <volume>5</volume>
                <fpage>331</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">17488636</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.zambrowicz.2003.14109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zambrowicz</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abuin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramirez-Solis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richter</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piggott</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>BeltrandelRio H, Buxton EC, Edwards J, Finch RA, Friddle CJ, Gupta A, Hansen G, Hu Y, Huang W, Jaing C, Key BW Jr, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Payne R, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Van Sligtenhorst I, Vogel P, Walke W, Xu N, Zhu Q, Person C, Sands AT. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2003</year>
                <volume>100</volume>
                <fpage>14109</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">14610273</pub-id>
              </element-citation>
            </ref>
            <ref id="pha2.REF.zhang.2013.545">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Novel missense mutations of WNK1 in patients with hypokalemic salt-losing tubulopathies.</article-title>
                <source>Clin Genet.</source>
                <year>2013</year>
                <volume>83</volume>
                <fpage>545</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">22934535</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="pha2.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="pha2.Suggested_Reading.reflist0">
            <ref id="pha2.REF.zhang.2011.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Identification of a novel WNK4 mutation in Chinese patients with pseudohypoaldosteronism type II.</article-title>
                <source>Nephron Physiol.</source>
                <volume>118</volume>
                <fpage>53</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">21196779</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="pha2.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="pha2.Author_History">
          <title>Author History</title>
          <p>David H Ellison, MD (2017-present)Kristopher T Kahle, MD, PhD; Harvard Medical School (2011-2017)Frederick H Wilson, MD, PhD; Harvard Medical School (2011-2017)</p>
        </sec>
        <sec id="pha2.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>16 February 2017 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>16 January 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>10 November 2011 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>25 April 2011 (ktk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
